Lipid, lipase and lipocalin differences between tolerant and intolerant contact lens wearers

Current Eye Research

Volumn 25, Issue 4, 2002, Pages 227-235

  Glasson, M J ^a   Stapleton, F ^a   Willcox, Mark D P ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Contact lens; Lipocalin; Phospholipase; Phospholipid; Tear film

Indexed keywords

4 HYDROXYNONENAL; LIPID; LIPOCALIN; MALONALDEHYDE; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL LIPASE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTACT LENS; CONTROLLED STUDY; DRY EYE; DYNAMICS; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LACRIMAL FLUID; LIPID DEGRADATION; MALE; PRIORITY JOURNAL; SOFT CONTACT LENS; SPECTROPHOTOMETRY; SYMPTOMATOLOGY; TEAR FILM;

ADULT; CARRIER PROTEINS; CASE-CONTROL STUDIES; CONTACT LENSES; CONTACT LENSES, EXTENDED-WEAR; DRY EYE SYNDROMES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; LIPASE; LIPID METABOLISM; MALE; PHOSPHOLIPASES A; PROSPECTIVE STUDIES; REFERENCE VALUES; TEARS;

EID: 0036820456     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.25.4.227.13482     Document Type: Article

References (69)

1. Mainstone JC, Bruce AS, Golding TR. Tear meniscus measurements in the diagnosis of dry eye. Curr Eye Res. 1996;15:653-661.
2. Glasson MJ, Keay L, Willcox MDP. Understanding the reasons why some patients are intolerant to soft contact lens wear. Invest Ophthalmol Vis Sci. 2000:41(4):S73.
3. Golding TR, Bruce AS, Mainstone JC. Relationship between tear-meniscus parameters and tear-film breakup. Cornea. 1997;16:649-661.
4. Glasgow BJ, Marshall G, Gasymov OK, Abduragimov AR, Yusifov TN, Knobler CM. Tear lipocalins: Potential lipid scavengers for the corneal surface. Invest Ophthalmol Vis Sci. 1999;40:3100-3107.
5. McCulley JP, Shine W. A compositional based model for the tear film lipid layer. Trans Am Ophthalmol Soc. 1997;95:79-88.
6. Greiner JV, Glonek T, Korb DR, Leahy CD. Meibomian gland phospholipids. Curr Eye Res. 1996;15:371-375.
7. Korb DR, Greiner JV, Glonek T. Tear film lipid layer formation: Implications for contact lens wear. Optom Vis Sci. 1996;73:189-192.
8. Shine WE, McCulley JP. Keratoconjunctivitis sicca associated with meibomian secretion polar lipid abnormality. Arch Ophthalmol. 1998;116:849-852.
9. Craig JP, Tomlinson A. Importance of the lipid layer in human tear film stability and evaporation. Optom Vis Sci. 1997;74:8-13.
10. Iwata S, Lemp MA, Holly FJ, Dohlman CH. Evaporation rate of water from the precorneal tear film and cornea in the rabbit. Invest Ophthalmol. 1969;8:613-619.
11. Korb DR, Greiner JV, Glonek T, Whalen A, Hearn SL, Esway JE, Leahy CD. Human and rabbit lipid layer and interference pattern observations. Adv Exp Med Biol. 1998;438:305-308.
12. Nicolaides N, Kaitaranta JK, Rawdah TN, Macy JI, Boswell FM 3d, Smith RE. Meibomian gland studies: Comparison of steer and human lipids. Invest Ophthalmol Vis Sci. 1981;20:522-536.
13. King-Smith PE, FinkBA, Fogt N. Three interferometric methods for measuring the thickness of layers of the tear film. Optom Vis Sci. 1999;76:19-32.
14. Redl B, Holzfeind P, Lottspeich F. cDNA cloning and sequencing reveals human tear prealbumin to be a member of the lipophilic-ligand carrier protein superfamily. J Biol Chem. 1992;267:20282-20287.
15. Delaire A, Lassagne H, Gachon AMF. New members of the lipocalin family in human tear fluid. Exp Eye Res. 1992;55:645-647.
16. Gachon AM, Lacazette E. Tear lipocalin and the eye's front line of defence. Br J Ophthalmol. 1998;82:453-455.
17. Glasgow BJ, Abduragimov AR, Farahbakhsh ZT, Faull KF, Hubbell WL. Tear lipocalins bind a broad array of lipid ligands. Curr Eye Res. 1995;14:363-372.
18. Fullard RJ, Kissner DM. Purification of the isoforms of tear specific prealbumin. Curr Eye Res. 1991;10:613-628.
19. Fullard RJ, Snyder C. Protein levels in nonstimulated and stimulated tears of normal human subjects. Invest Ophthalmol Vis Sci. 1990;31:1119-1126.
20. Evans V, Cordwell S, Vockler C, Willcox MDP. Ten isoforms of human tear lipocalin demonstrated with 2D-PAGE and MALD1-TOF analysis. Invest Ophthalmol Vis Sci. 2000;41(4):S69.
21. Gasymov OK, Abduragimov AR, Yusifov TN, Glasgow BJ. Structural changes in tear lipocalins with ligand binding. Biochim Biophys Acta. 1998;1386:145-156.
22. Flower DR, North AC, Attwood TK. Structure and sequence relationships in the lipocalins and related proteins. Protein Sci. 1993;2:753-761.
23. Nevelainen TJ, Aho HJ, Peuravuori H. Secretion of group 2 phospholipase A2 by lacrimal gland. Invest Ophthalmol Vis Sci. 1994;35:417-421.
24. Song CH, Choi JS, Kim DK, Kim JC. Enhanced secretory group II PLA2 activity in the tears of chronic blepharitis patients. Invest Ophthalmol Vis Sci. 1999;40:2744-2748.
25. 2 content of tears in normal subjects. Invest Ophthalmol Vis Sci. 2001;42:318-320.
26. 2 and lysozyme in lacrimal glands. Invest Ophthalmol Vis Sci. 1996;37:1826-1832.
27. Vadas P, Browning J, Edelson J, Pruzanski W. Extracellular phospholipase A2 expression and inflammation: The relationship with associated disease states. J Lipid Mediat. 1993;8:1-30.
28. Harwig SSI, Tan L, Qu XD, Cho Y, Eisenhauer PB, Lehrer RI. Bactericidal properties of murine intestinal phospholipase A2. J Clin Invest. 1995;95:603-610.
29. Weinrauch Y, Elsbach P, Madsen EM, Foreman A, Weiss J. The potent anti-staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14 kDa phospholipase A2. J Clin Invest. 1996;97:250-257.
30. 2 in the pathobiology of disease. Lab Invest. 1986;55:391-404.
31. 2 activity in the tears of chronic blepharitis patients. Invest Ophthalmol Vis Sci. 1999;40:2744-2748.
32. 2 and lysozyme in lacrimal gland. Invest Ophthalmol Vis Sci. 1996;37:1826-1832.
33. Zheng L, Zomerdijk TP, Van Den Barselaar MT, Geertsma MF, Van Furth R, Nibbering PH. Arachidonic acid, but not its metabolites, is essential for FcgammaR-stimulated intra-cellular killing of Staphylococcus aureus by human monocytes. Immunology. 1999;96:90-97.
34. Lennartz MR, Brown EJ. Arachidonic acid is essential for 1gG Fc receptor-mediated phagocytosis by human monocytes. J Immunol. 1991;147:621-626.
35. Dennis EA, Rhee SG, Billah MM, Hannun YA. Role of phospholipase in generating lipid second messengers in signal transduction. FASEB J. 1991;5:2068-2077.
36. McMonnies CW. Key questions in a dry eye history. J Am Opt Assoc. 1986;57:512-517.
37. Glasson MJ, Molloy MP, Walsh BJ, Morris CA, Williams KL. Development of mini-gel technology in two-dimensional electrophoresis for mass-screening of samples: Application to tears. Electrophoresis. 1998;19:652-855.
38. Glasson MJ, Hseuh S, Willcox MDP. Preliminary tear film measurements of tolerant and non-tolerant contact lens wearers. Clin Exp Optom. 1999;82:177-181.
39. Carney FP, Morris CA, Willcox MDP. Effect of hydrogel lens wear on the major tear proteins during extended wear. Aust NZ J Ophthalmol. 1997;25:S36-S38.
40. Tan A, Sack RA, Holden BA, Swarbrick HA. Temporal sequence of changes in tear film composition during sleep. Curr Eye Res. 1993;12:1001-1007.
41. Sack RA, Tan KO, Tan A. diurnal tear cycle: Evidence for a nocturnal inflammatory constituitive tear fluid. Invest Ophthalmol Vis Sci. 1992;33:626-640.
42. Fullard RJ, Tucker DL. Changes in human tear protein levels with progressively increasing stimulus. Invest Ophthalmol Vis Sci. 1991;32:2290-2301.
43. Connor CG, Flockencier LL, Hall CW. The influence of gender on the ocular surface. J Am Opt Assoc. 1999;70:182-186.
44. Mulvenna I, Stapleton F, Hains PG, Cengiz A, Tan M, Walsh B, Holden B. Low molecular weight analysis of tears using matrix assisted laser desorption ionization-time of flight mass spectrometry. Clin Exp Ophthalmol. 2000;28:205-207.
45. Barton K, Nava A, Monroy DC, Pflugfelder SC. Cytokines and tear function in ocular surface disease. Adv Exp Med Biol. 1998;438:461-469.
46. Gachon A-M, Richard J, Dastugue B. Human tears: Normal protein pattern and individual protein determinations in adults. Curr Eye Res. 1983;2:301-308.
47. Tomlinson A, Pearce EI, Simmons PA, Blades K. Effect of oral contraceptives on tear physiology. Ophthal Physiol Opt. 2001;21:9-16.
48. Willcox MDP, Lan J. Secretory immunoglobulin A in tears: Functions and changes during contact lens wear. Clin Exp Optom. 1999;82:1-3.
49. Stapleton F, Willcox MDP, Morris CA, Sweeney DF. Tear changes in contact lens wearers following overnight eye closure. Curr Eye Res. 1998;17:183-188.
50. Carney FP, Keay L, Stapleton F, Morris CA, Willcox MDP. Hydrogel lens wettability and deposition in vivo. Clin Exp Optom. 1998;81:51-55.
51. Guillon JP, Guillon M. Tear film examination of the contact lens patient. Contax. 1998;May:14-18.
52. Baeir G, Wollensak G, Mur E, Redl B, Stoffler G, Gottinger W. Analysis of human tear proteins by different high-performance chromatographic techniques. J Chromatogr. 1990;525:319-328.
53. Erdfelder E, Faul F, Buchner A. GPOWER: A general power analysis program. Behaviour Res Methods. Instruments & Computers. 1996;28:1-11.
54. th ed. New Jersey: Prentice-Hall Inc; 1995:204-205.
55. Papas EB, Vajdic CM. Inter-ocular characteristics of the pre-contact lens tear film. Curr Eye Res. 2000;20:248-250.
56. Jumblatt MM, McKenzie RW, Jumblatt JE. Mucins of the ocular surface. Cornea. 2000;19(Suppl 2):S97.
57. Murty VLN, Sarosiek J, Slomiany A, Slomiany BL. Effect of lipids and proteins on the viscosity of gastric mucus glycoproteins. Biochem Biophys Res Comm. 1984;121:521-529.
58. Gong DH, Turner B, Bhaskar KR, Lamont JT. Lipid binding to gastric mucin: Protective effect against oxygen radicals. Am J Physiol. 1990;259:G681-G686.
59. Shine WE, McCulley JP. Association of meibum oleic acid with meibomian seborrhea. Cornea. 2000;19:72-74.
60. McMonnies CW, Ho A, Wakefield D. Optimum dry eye classification using questionnaire responses. In: Sullivan DA et al., eds. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. New York: Plenum Press; 1998:835-838.
61. Boyaka PN, McGhee JR. Cytokines as adjuvants for the induction of mucosal immunity. Adv Drug Deliv Rev. 2001;51:71-79.
62. Yomogida S, Nagaoka I, Saito K, Yamashita T. Evaluation of the effects of defensins on neutrophil functions. Inflamm Res. 1996;45:62-67.
63. Yang D, Chertov O, Oppenheim JJ. Participation of mammalian defensins and cathelicidins in anti-microbial immunity: Receptors and activities of human defensins and cathelicidin (LL-37). J Leukoc Biol 2001;69:691-697.
64. McNamara NA, Van R, Tuchin OS, Fleiszig SM. Ocular surface epithelia express mRNA for human beta defensin-2. Exp Eye Res. 1999;69:483-490.
65. Redl B, Wojnar P, Ellemunter H, Feichtinger H. Identification of a lipocalin in mucosal glands of the human tracheobronchial tree and its enhanced secretion in cystic fibrosis. Lab Invest. 1998;78:1121-1129.
66. Tiffany JM, Pandit JC, Bron AJ. Soluble mucin and the physical properties of tears. In: Sullivan DA et al., eds. Lacrimal Gland, Tear Film, and Dry Eye Syndromes 2. New York, USA: Plenum Press; 1998:229-234.
67. Nagyova B, Tiffany JM. Components responsible for the surface tension of human tears. Curr Eye Res. 1999;19:4-11.
68. Pandit JC, Nagyova B, Bron AJ, Tiffany JM. Physical properties of stimulated and unstimulated tears. Exp Eye Res. 1999;68:247-253.
69. Greiner JV, Glonek T, Korb DR, Leahy CD. Meibomian gland phospholipids. Curr Eye Res. 1996;15:371-375.